Analysts covering AbbVie have been fine tuning their models, with fair value per share adjusted slightly from US$245.22 to ...
Clinical Trials Arena on MSN
SLE: Four trials to watch in 2026
As The European Lupus Society’s 15th annual soiree approaches, the Clinical Trials Arena team takes a look at four promising ...
14hon MSNOpinion
Some health care CEOs praise TrumpRX for empowering consumers to compare drug prices
Also: All the news and watercooler chat from Fortune.
Studies evaluating the oral JAK inhibitor in adults and adolescents with non-segmental vitiligo are submitted for approval of the expanded indication.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results